129 related articles for article (PubMed ID: 8518247)
41. Measurement of placental protein 14 (PP14) not helpful in predicting infertility or spontaneous abortion.
Check JH; Vaze MM; Vetter B
Int J Fertil Menopausal Stud; 1993; 38(1):34-6. PubMed ID: 8485609
[TBL] [Abstract][Full Text] [Related]
42. Concentrations of endometrial protein PP 14 and CA-125 in uterine flushings performed in natural and stimulated cycles.
Ng EH; Laird SM; Li TC; Yeung WS; Ho PC
Hum Reprod; 2004 Apr; 19(4):905-10. PubMed ID: 15016783
[TBL] [Abstract][Full Text] [Related]
43. A prospective randomized controlled study comparing two doses of gestodene in cyclic combined HRT preparations on endometrial physiology.
Okon MA; Lee S; Laird SM; Li TC
Hum Reprod; 2001 Jun; 16(6):1244-50. PubMed ID: 11387299
[TBL] [Abstract][Full Text] [Related]
44. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
[TBL] [Abstract][Full Text] [Related]
45. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle.
Durand M; Seppala M; Cravioto Mdel C; Koistinen H; Koistinen R; González-Macedo J; Larrea F
Contraception; 2005 Jun; 71(6):451-7. PubMed ID: 15914136
[TBL] [Abstract][Full Text] [Related]
46. The production of placental protein 14 and interleukin 6 by human endometrial cells in culture.
Laird SM; Li TC; Bolton AE
Hum Reprod; 1993 Jun; 8(6):793-8. PubMed ID: 8345065
[TBL] [Abstract][Full Text] [Related]
47. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibodies against endometrial protein PP14 and their use for purification and radioimmunoassay of PP14.
Riittinen L; Närvänen O; Virtanen I; Seppälä M
J Immunol Methods; 1991 Jan; 136(1):85-90. PubMed ID: 1995715
[TBL] [Abstract][Full Text] [Related]
49. The post-menopausal uterus: the effect of hormone replacement therapy on the serum levels of secretory endometrial protein PP14/beta-lactoglobulin homologue.
Seppälä M; Alfthan H; Vartiainen E; Stenman UH
Hum Reprod; 1987 Nov; 2(8):741-3. PubMed ID: 2830296
[TBL] [Abstract][Full Text] [Related]
50. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
51. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
52. Progestin-dependent human endometrial protein: a marker for monitoring human endometrial function.
Joshi SG
Adv Exp Med Biol; 1987; 230():167-86. PubMed ID: 3135704
[TBL] [Abstract][Full Text] [Related]
53. Regulation of the glycosylated beta-lactoglobulin homolog, glycodelin [placental protein 14:(PP14)] in the baboon (Papio anubis) uterus.
Hausermann HM; Donnelly KM; Bell SC; Verhage HG; Fazleabas AT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1226-33. PubMed ID: 9543146
[TBL] [Abstract][Full Text] [Related]
54. The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen.
Byrjalsen I; Riis BJ; Christiansen C
Gynecol Endocrinol; 1989 Jun; 3(2):143-52. PubMed ID: 2816479
[TBL] [Abstract][Full Text] [Related]
55. Secretory endometrium synthesizes placental protein 14.
Julkunen M; Koistinen R; Sjöberg J; Rutanen EM; Wahlström T; Seppälä M
Endocrinology; 1986 May; 118(5):1782-6. PubMed ID: 3516653
[TBL] [Abstract][Full Text] [Related]
56. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
[TBL] [Abstract][Full Text] [Related]
57. Circulating levels of placental protein 14 in ectopic pregnancy.
Stabile I; Olajide F; Chard T; Grudzinskas JG
Br J Obstet Gynaecol; 1994 Sep; 101(9):762-4. PubMed ID: 7947525
[TBL] [Abstract][Full Text] [Related]
58. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy.
Byrjalsen I; Thormann L; Meinecke B; Riis BJ; Christiansen C
Hum Reprod; 1992 Sep; 7(8):1042-7. PubMed ID: 1400926
[TBL] [Abstract][Full Text] [Related]
59. Endometrial glycodelin-A expression in the luteal phase of stimulated ovarian cycles.
Brown SE; Mandelin E; Oehninger S; Toner JP; Seppala M; Jones HW
Fertil Steril; 2000 Jul; 74(1):130-3. PubMed ID: 10899509
[TBL] [Abstract][Full Text] [Related]
60. The effect of hysteroscopic polypectomy on the concentrations of endometrial implantation factors in uterine flushings.
Ben-Nagi J; Miell J; Yazbek J; Holland T; Jurkovic D
Reprod Biomed Online; 2009 Nov; 19(5):737-44. PubMed ID: 20021724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
